Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Matthew F Mescher"'
Autor:
Kevin H. Mayo, Arjan W. Griffioen, Michael A. Farrar, Matthew F. Mescher, Mirjam G.A. oude Egbrink, Yan Zhang, Flavia Popescu, Karolien Castermans, Kieng B. Vang, Ruud P.M. Dings
Purpose: Tumor-released proangiogenic factors suppress endothelial adhesion molecule (EAM) expression and prevent leukocyte extravasation into the tumor. This is one reason why immunotherapy has met with limited success in the clinic. We hypothesized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1897464c422f968fc410e1ee79855db8
https://doi.org/10.1158/1078-0432.c.6518661.v1
https://doi.org/10.1158/1078-0432.c.6518661.v1
Autor:
Kevin H. Mayo, Arjan W. Griffioen, Michael A. Farrar, Matthew F. Mescher, Mirjam G.A. oude Egbrink, Yan Zhang, Flavia Popescu, Karolien Castermans, Kieng B. Vang, Ruud P.M. Dings
Supplementary Figures S1-S5; Supplementary Tables S1-S2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3065a0e617b32d3ed4d3d25a6310911e
https://doi.org/10.1158/1078-0432.22441701
https://doi.org/10.1158/1078-0432.22441701
Autor:
Brian T. Fife, Matthew F. Mescher, Christopher G. Tucker, Jason S. Mitchell, Lovejot M. Singh, Joseph C. Wilson, Alexander J. Dwyer, Lalit K. Beura, Brandon J. Burbach, Tijana Martinov
Publikováno v:
J Immunol
Optimal ex vivo expansion protocols of tumor-specific T cells followed by adoptive cell therapy must yield T cells able to home to tumors and effectively kill them. Our previous study demonstrated ex vivo activation in the presence of IL-12–induced
Autor:
Daisuke Ito, Katie L. Anderson, Kristin M. Snyder, Matthew F. Mescher, Lauren J. Mills, Debra C. Lins, Aaron M. Ring, Kipp Weiskopf, Yoji Shimizu, Irving L. Weissman, Jaime F. Modiano, Nan Guo Ring
Publikováno v:
Melanoma Research
Supplemental Digital Content is available in the text.
Therapeutic activation of macrophage phagocytosis has the ability to restrain tumour growth through phagocytic clearance of tumour cells and activation of the adaptive immune response. Our o
Therapeutic activation of macrophage phagocytosis has the ability to restrain tumour growth through phagocytic clearance of tumour cells and activation of the adaptive immune response. Our o
Autor:
Jaime F. Modiano, Matthew F. Mescher, Debra C. Lins, Aaron M. Ring, Lauren J. Mills, Irving L. Weissman, Nan Guo Ring, Yoji Shimizu, Katie L. Anderson, Daisuke Ito, Kristin M. Snyder, Kipp Weiskopf
Publikováno v:
Cancer Immunology Research. 7:A051-A051
Therapeutic activation of macrophage phagocytosis has the ability to restrain tumor growth through phagocytic clearance of tumor cells and activation of the adaptive immune response. Our objective for this study was to evaluate the effects of modulat
Publikováno v:
The Journal of Immunology. 191:3681-3693
A hallmark of T cell activation in vitro and in vivo is the clustering of T cells with each other via interaction of the LFA-1 integrin with ICAM-1. The functional significance of these homotypic aggregates in regulating T cell function remains unkno
Publikováno v:
The Journal of Immunology. 191:1011-1015
Naive CD8 T cells proliferate in response to TCR and CD28 signals, but require IL-12 or type I IFN to survive and develop optimal effector functions. Although murine CTL generated in vitro in response to IL-12 or IFN-α had comparable effector functi
Publikováno v:
The Journal of Immunology. 189:659-668
Autocrine IFN-γ signaling is important for CD4 differentiation to Th1 effector cells, but it has been unclear whether it contributes to CD8 T cell differentiation. We show in this paper that naive murine CD8 T cells rapidly and transiently produce l
Publikováno v:
Vaccinology
Autor:
Jeffrey S. Miller, Jaime F. Modiano, Julie M. Curtsinger, Michael S. Henson, V. S. Larson, J. S. Klausner, Matthew F. Mescher
Publikováno v:
Veterinary and Comparative Oncology. 9:95-105
Cytotoxic T-lymphocyte responses to subcellular antigens are enhanced when antigens are presented on cell-sized silica microbeads called large multivalent immunogens (LMIs). LMIs prepared with tumour cell membrane fragments have induced partial remis